login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NOVOCURE LTD (NVCR) Stock News
NASDAQ:NVCR -
JE00BYSS4X48
-
Common Stock
12.33
USD
+0.3 (+2.54%)
Last: 8/29/2025, 8:00:02 PM
12.33
USD
0 (0%)
After Hours:
8/29/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVCR Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: The Motley Fool
- Mentions:
VKTX
LLY
NVO
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
4 days ago - By: Novocure
Novocure Announces Upcoming Investor Events
7 days ago - By: Novocure
Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
10 days ago - By: Zacks Investment Research
- Mentions:
LMAT
EHC
NVST
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
12 days ago - By: Novocure
Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
a month ago - By: Benzinga
- Mentions:
MOH
HCA
Top 3 Health Care Stocks That May Explode In July
a month ago - By: The Motley Fool
Novocure: Steady Ahead of Key Milestones
19 days ago - By: Yahoo Finance
Leerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR)
a month ago - By: Benzinga
- Mentions:
CYH
WST
SRPT
HCTI
...
12 Health Care Stocks Moving In Thursday's Intraday Session
a month ago - By: Novocure
Novocure Reports Second Quarter 2025 Financial Results
2 months ago - By: Novocure
Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025
2 months ago - By: Novocure
Novocure to Report Second Quarter 2025 Financial Results
3 months ago - By: Yahoo Finance
- Mentions:
SHOP
WFC
NVDA
S
...
Why Shopify Stock Popped Today
3 months ago - By: Zacks Investment Research
- Mentions:
ANGO
CVS
ITGR
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
3 months ago - By: Novocure
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
3 months ago - By: Yahoo Finance
- Mentions:
AMZN
CP
UBER
GOOG
...
Billionaire Investor Bill Ackman Just Sold This Railway Stock 'With Regret' So He Could Buy the Dip on a Mag Seven Stock At a "Uniquely Attractive Time"
3 months ago - By: Yahoo Finance
- Mentions:
TSCO
BKH
D
LDOS
...
1 Excellent Dividend Stock to Buy Right Now
3 months ago - By: Novocure
Novocure Announces Upcoming Investor Events
4 months ago - By: Yahoo Finance
- Mentions:
CAVA
TSHA
TTWO
AMAT
...
Cava: Rapid Growth but Some Concerns
4 months ago - By: Zacks Investment Research
Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect?
4 months ago - By: Zacks Investment Research
Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High?
4 months ago - By: Yahoo Finance
- Mentions:
T
VZ
DHI
CMG
...
Why NovoCure Stock Skyrocketed This Week
4 months ago - By: Yahoo Finance
Why NovoCure Stock Leaped 4% Higher Today
4 months ago - By: Zacks Investment Research
NovoCure (NVCR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
4 months ago - By: Novocure
Novocure Reports First Quarter 2025 Financial Results
Please enable JavaScript to continue using this application.